You’ve heard the dramatic weight loss stories. Semaglutide, the active ingredient in Ozempic and Wegovy, can help people lose 15 percent of their body weight. Tirzepatide, sold under the brand names Mounjaro and Zepbound, may be even more effective at shedding pounds.
Known as GLP-1 agonists, these drugs were originally developed to help control diabetes. But there’s increasing evidence that they have other health benefits, beyond controlling weight. They seem to boost heart health, protect the kidneys, improve sleep apnea, and lower the risk of certain obesity-related cancers. Recent studies have also hinted at their potential to treat
→ Continue reading at Wired - Science